In this cohort of patients who underwent ERM surgery, diabetes, glycemic control or need for insulin medication, were not associated with worse outcomes, regardless of topical NSAIDs anti-inflammatory adjunct therapy. This evidence concerns the gene INS and diabetes mellitus.